Subscribe
Today
Financial
Technology
Cyclical
Defensive
Healthcare
Energy
Industrials
Real Estate
Materials
Viewpoints
All Access Articles |
NBIX
Neurocrine Biosciences Reports Positive Results for Schizophrenia Drug
| 2024-08-28 |
BIOTECHNOLOGY
Uncovering Missed Opportunities in Neurocrine Biosciences (NBIX)
| 2024-03-27 |
BIOTECHNOLOGY
Thinking of Investing in NBIX? What Our Analysts Know.
| 2023-04-29 |
BIOTECHNOLOGY
